I would agree with the general statement. There are widely accepted additional requirements when data could be associated with an individual in any conceivable way, and certainly in medicine and epidemiology, when private health information is included, there are additional levels of scrutiny and security.
I'll just clarify that BlueDot does not hold any personal information across any of our holdings, in mobility data or beyond. We don't have any private health information in our system in any sense. That would require substantially more investment in privacy and security, and different trade-offs between goods such as public security in the context of a pandemic and other valid goods, like personal privacy.